--- title: 'Medical Science Liaison (South US or Eastern US) at Ossium Health' canonical: 'https://feeny.ai/job/medical-science-liaison-south-us-or-eastern-us-ossium-health-field-based-eastern-m6sfav5wsy7a' type: 'job' last_seen: '2026-09-14' --- # Medical Science Liaison (South US or Eastern US) at Ossium Health - **Company:** Ossium Health - **Location:** Field-Based Eastern, United States / Field-Based Southeastern, United States - **Work type:** remote - **Posted:** 2026-06-18 - **Last confirmed live:** 2026-09-14 - **Apply:** https://ossiumhealth.com/jd?gh_jid=4690578006 ## Job description ## About Ossium Ossium’s mission is to improve the health, vitality, and longevity of human beings through bioengineering. We develop, manufacture, and bank cell therapy products that apply the power of stem cell science to revolutionize treatment for patients with blood, immune, and orthopedic diseases.  At Ossium, we empower our employees, maintain the highest standards of operational excellence, and are a force for good. ## About the Job We're hiring a Medical Science Liaison to be the bridge between our cutting-edge cryopreserved deceased donor bone marrow technology and the hematology/oncology and transplant medicine community. As the scientific voice of Ossium, you’ll build relationships with key opinion leaders, translate complex science into compelling clinical narratives, and help physicians and transplant care teams understand how our products transform patient outcomes. This isn't a traditional pharma MSL role. You'll be working with breakthrough cell therapy technology at an early-stage company, which means real autonomy, meaningful scientific impact, and a direct line to clinical development decisions. This role will be instrumental in building scientific community awareness and supporting our clinical development efforts in the hematology/oncology and transplant medicine space. We are looking for MSLs in either the South or the Eastern region of the United States. Required Qualifications - Advanced degree (PharmD, PhD, MD, DNP, or MS) in life sciences, medicine, or a related field - 7+ years of experience as an MSL in the U.S. - Domain experience in stem cell transplant, cell therapy, and/or gene therapy - Experience engaging academic medical centers or complex hospital systems - Experience and comfort presenting scientific data to healthcare professionals - Ability to operate independently in the field and manage a regional territory - Experience working with academic medical centers or complex hospital systems - Willingness to travel up to 70% (mostly regional, some national conferences) - Excellent written and oral communication skills - High organizational discipline; ability to thrive in a dynamic startup environment - Candidates must be based in either the South or the Eastern region of the United States ## Preferred Qualifications - Clinical experience and existing professional relationships in hematology/oncology or transplant medicine - KOL engagement and advisory board experience - Track record of successful medical conference presentations ## Key Responsibilities - Build and maintain relationships with hematology, oncology, and transplant medicine KOLs in your region - Educate physicians and transplant care teams throughout your region on Ossium’s science and clinical value proposition - Present clinical data at medical conferences and scientific meetings - Support clinical trial recruitment and investigator engagement - Respond to medical information requests from healthcare professionals - Support advisory boards and scientific advisory meetings - Collaborate with R&D, Clinical, Commercial, Marketing, and Regulatory on scientific communications - Monitor the competitive landscape, gather and synthesize market insights - Contribute to medical publications and conference abstracts In your first six months, some projects you’ll work on include: - Identifying key transplant centers in your region, building and nurturing relationships with 15-20 KOLs - Attending scientific conferences and connecting with key transplant care providers - Creating and presenting scientific materials for Ossium’s bone marrow products - Expanding Ossium’s physician education program We Offer a Full Slate of Employee Benefits Including: - Competitive salaries - Stock options - 401(k) matching - Medical, dental, and vision coverage - Four weeks of PTO accrued annually (vacation & sick time) + 11 company holidays - Employer paid life insurance and long-term disability - Gym membership and recreational sports reimbursements Ossium Health provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, disability, protected veteran status, sexual orientation, gender identity, gender expression, or any other protected characteristic. Our [Equal Employment Opportunity Policy Statement](https://ossiumhealth.com/wp-content/uploads/2025/05/Ossium-Health-2024-Equal-Employment-Opportunity-Policy-Statement.pdf) and the [Know Your Rights: Workplace Discrimination is Illegal Poster](https://www.eeoc.gov/sites/default/files/2023-06/22-088_EEOC_KnowYourRights6.12.pdf) reaffirm this commitment. Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records. If reasonable accommodation is needed, please contact our People Team at careers@ossiumhealth.com or 650-285-0603. Ossium Health complies with federal and state disability laws and makes reasonable accommodations for applicants and candidates with disabilities. Principals / direct applicants only please. Recruiters, please do not contact this job poster. ## Equal Opportunity Employer/Veterans/Disabled ## About Ossium Health ## Company Overview - **One-liner**: Ossium Health is a clinical-stage bioengineering company that creates life-saving stem cell therapies from deceased donors for use in bone marrow transplants and other blood and immune system diseases. - **Entity Type**: Private (Series C) - **Headquarters**: San Francisco, California, USA (with a manufacturing facility in Indianapolis, Indiana, USA) - **Founded**: 2016 - **Founders**: Kevin Caldwell (CEO, Co-Founder) and Erik Woods (Chief Science Officer, Co-Founder) ## Core Business - **Industry**: Biotechnology / Cell Therapy - **Target Customers**: B2B – healthcare providers (transplant centers), life science companies (biopharma partners), and organ procurement organizations (OPOs) - **Mission**: “To improve human health through bioengineering” and “Establish a new source for life-saving stem cells” by bringing the deceased donor transplant ecosystem into the fight against diseases of the blood and immune systems. ## Products & Services - **HPC, Marrow (Hematopoietic Progenitor Cells from marrow)**: An allogeneic stem cell product derived from vertebral body donors, used in bone marrow transplants. First patient successfully engrafted at Henry Ford Health in June 2024. - **OssiGraft**: An orthopedic product (first patient treated November 2023) – marks the company’s entry into orthopedics. - **CD34+ Product**: A purified hematopoietic stem cell product used in a multivisceral transplant study at Columbia University Medical Center (first patient November 2021). - **Platform Model**: A proprietary process for recovering, processing, and cryopreserving cells from deceased donors, enabling off-the-shelf cell therapies. ## Market Standing - **Valuation/Market Cap**: Not disclosed - **Key Metric**: **Total Funding** – USD 128.9 million across multiple rounds (Seed, Series A, Series B, Series C, and a grant) - **Notable Investors/Partners**: - Lead investors: CPMG (Series C lead), Vivo Capital (Series B co-lead), General Catalyst (Series B co-lead), First Round Capital (Series A lead) - Other investors: Manta Ray Ventures, Village Global, Asahi Kasei, Alumni Ventures - Federal partner: Biomedical Advanced Research and Development Authority (BARDA) – contract for radiological/nuclear emergency preparedness - **Growth Signals**: - Headcount: ~75 employees, with +13.3% yearly growth (LinkedIn) - Active job postings: 14 (as of mid-2025) - Recent clinical milestones: first patient engrafted with HPC Marrow (June 2024) and first OssiGraft patient (Nov 2023) - Series C closed July 2023 ($52M) - Expanded into orthopedics and federal preparedness markets ## Competitive Advantages - **Unique Cell Source**: Uses deceased donors (vertebral bodies) rather than living donors or iPSCs, leveraging an existing transplant network to produce scalable, off-the-shelf allogeneic cell therapies. - **Proprietary Processing & Cryopreservation**: Founders have deep expertise in cryobiology; Dr. Woods co-invented the first closed-system cryovial for cell therapy (CellSeal®) and commercial human platelet lysate (Stemulate®). - **Regulatory & Operational Infrastructure**: CLIA-certified lab, FDA-registered facility, and AABB accreditation; experienced in high-complexity clinical cell manufacturing. - **Government Partnership**: BARDA contract validates the platform for national emergency preparedness, providing a stable, non-dilutive revenue stream and strategic credibility. ## Strategic Focus - Advance clinical trials for HPC Marrow in bone marrow transplant (lead indication) and expand into orthopedics with OssiGraft. - Strengthen partnerships with OPOs and healthcare systems to increase donor tissue access. - Scale manufacturing capacity at the Indianapolis facility to meet commercial and federal contract demand. - Continue to develop additional cell therapy programs (e.g., immune effector cells, mesenchymal stromal cells) using the same platform. ## Why Work Here - **Culture & Values**: Emphasizes Truth (data-driven decision making), Ownership (high accountability), Grit (persistence toward mission), and Impact (improving human health). - **Mission-Driven**: Employees are motivated by the chance to fight diseases like leukemia and lymphoma, and to contribute to national health security (BARDA partnership). - **Work Environment**: Two locations – San Francisco HQ (office) and Indianapolis facility (cell manufacturing lab). Roles span clinical production, recovery services, quality assurance, research, and commercial. Likely on-site for lab and manufacturing roles. - **Growth Opportunity**: Rapidly scaling company with recent clinical wins and a growing headcount; employees can take ownership of impactful projects early in their careers. - **Notable Perks**: Not detailed in search results, but the company highlights “empowering employees, maintaining the highest standards of excellence, and being a force for good.” ## Sources 1. [Ossium Health – Careers Page](https://ossiumhealth.com/careers/) 2. [Ossium Health – Homepage](https://ossiumhealth.com/) 3. [Ossium Health – Company About](https://ossiumhealth.com/company/) 4. [Ossium Health – Our Team](https://ossiumhealth.com/our-team/) 5. [Ossium Health – LinkedIn Company Profile](https://www.linkedin.com/company/ossiumhealth) ## Other roles at Ossium Health - [Clinical Production Operator I/II, HPC Marrow](https://feeny.ai/job/clinical-production-operator-i-ii-hpc-marrow-ossium-health-indianapolis-93rvybbnct02) — Indianapolis, IN - [Medical Science Liaison (Western US)](https://feeny.ai/job/medical-science-liaison-western-us-ossium-health-west-4g1v5n63v6s4) — West - [Field Accounts Manager (West)](https://feeny.ai/job/field-accounts-manager-west-ossium-health-field-based-western-gxaa70zxn81g) — Field-Based Western, United States - [Field Accounts Manager (Central)](https://feeny.ai/job/field-accounts-manager-central-ossium-health-field-based-central-551tcnkmzevn) — Field-Based Central, United States / Field-Based Southeastern, United States - [Chief Financial Officer](https://feeny.ai/job/chief-financial-officer-ossium-health-san-francisco-california-cra5q8ffrrrs) — San Francisco California, United States - [Tissue Recovery Specialist (Contract) - Northern OR Southern Indiana](https://feeny.ai/job/tissue-recovery-specialist-contract-northern-or-southern-indiana-ossium-health-rmvccntaz5r9) — Field Based: Northern, IN / Field Based: Southern, IN